Monday, February 8, 2016

Research discovers neuroprotective protein in blood is biomarker of Alzheimer’s disease

Medical professionals have to conduct a long series of tests to assess a patient’s memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer’s disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best—and subjective at worst.

from Dementia Big http://ift.tt/1olnoIH
via Stopping Dementia



from WordPress http://ift.tt/1W8S5eQ
via alcoholic dementia
http://ift.tt/1Q604et

No comments:

Post a Comment